Pretransplantation gastrointestinal bleeding

Liver Transplantation

Volumn 6, Issue 4 SUPPL. 1, 2000, Pages

  Lebrec, D ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; ISOSORBIDE MONONITRATE; NADOLOL; OCTREOTIDE; PROPRANOLOL; SOMATOSTATIN; TERLIPRESSIN; VASOPRESSIN;

CLINICAL FEATURE; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0033943412     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500060512     Document Type: Conference Paper

References (41)

1. Prior esophageal variceal bleeding does not adversely affect survival after orthotopic liver transplantation
2. Anti-inflammatory drugs and variceal bleeding: A case-control study
3. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients
4. Prediction of the first varicel hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study
5. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis
6. Variceal pressure is a factor predicting the risk of a first varicel bleeding: A prospective cohort study in cirrhotic patients
7. La mortalite des hemorragies digestives des cirrhoses a ete reduite de plus de moitie en 15 ans [abstract]
8. Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats
9. Effect of propranolol on prevention of first variceal bleed and survival in patients with chronic liver disease
10. Lack of effect of propranolol in the prevention of large esophageal varices in patients with cirrhosis: A randomized trial
11. β-Blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: Interim analysis of a placebo-controlled clinical trial [abstract]
12. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: An analysis of data and prognostic factors in 589 patients from four randomized clinical trials
13. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment
14. Meta-analysis of value of propranolol in prevention of variceal haemorrhage
15. The treatment of portal hypertension: A meta-analysis review
16. Pharmacological treatment of portal hypertension: Present and future
17. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis
18. Nadolol and isosorbide-5-mononitrate (Is-5-Mn) for preventing bleeding in cirrhotics with ascites [abstract]
19. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
20. Propranolol + placebo vs propranolol + isosorbide-5-mononitrate in the prevention of the first variceal bleeding. A multicenter double-blind randomized controlled trial [abstract]
21. Isosorbide mononitrate with nadolol compared to nadolol alone for prevention of first bleeding in cirrhosis, a double-blind placebo-controlled randomised trial [abstract]
22. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding
23. Baveno consensus statements Drug therapy for portal hypertension
24. Randomized controlled trial comparing terlipressin vs endoscopic injection sclerotherapy in the treatment of bleeding esophageal varices [abstract]
25. Randomized controlled trial of sclerotherapy vs somatostatin infusion in the prevention of early rebleeding following variceal hemorrhage in patients with cirrhosis [abstract]
26. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation
27. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices. A randomized, double-blind, placebo-controlled, multicenter trial
28. Sclerotherapy with or without octreotide for acute variceal bleeding
29. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European acute bleeding oesophageal variceal episodes (ABOVE) randomised trial
30. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients
31. The transjugular intrahepatic portosystemic shunt
32. Update on the role of transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of complications of portal hypertension
33. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board
34. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding
35. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis
36. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis
37. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleeding
38. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis
39. Nadolol plus isosorbide mononitrate compared with sclerotherapy of the prevention of variceal rebleeding
40. Randomized controlled trial comparing propranolol + isosorbide-5-mononitrate vs shunt surgery/sclerotherapy in the prevention of variceal rebleeding [abstract]
41. Isosorbide mononitrate with nadolol compared to nadolol alone for prevention of recurrent bleeding in cirrhosis. A double-blind placebo-controlled randomised trial [abstract]